Life360, Inc.
LIF Nasdaq Services-Computer Processing & Data Preparation Financials FY2020βFY2025
What Life360, Inc. does
No business description yet.
- Legal name
- Life360, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0001581760-26-000016
0001581760
Revenue and margins
Life360, Inc. had $489M of revenue in fiscal 2025, up 31.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $86.8M in fiscal 2025, 17.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Life360, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 18.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Life360, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $231M | $75.4M | $69.0M | $159M | $494M |
| Debt incl. finance leases | β | $7.6M | $4.5M | β | β |
| Debt / equity | β | 0.0x | 0.0x | β | β |
| Current ratio | 6.2x | 1.6x | 1.9x | 3.1x | 6.3x |
| Quick ratio | 6.1x | 1.5x | 1.8x | 3.0x | 6.2x |
| Total assets | $302M | $340M | $322M | $442M | $960M |
| Total liabilities | $52.3M | $95.1M | $74.7M | $83.0M | $412M |
| Shareholders' equity | $250M | $245M | $247M | $359M | $548M |
| Net debt (β = net cash) | β | β$67.9M | β$64.5M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 2 / 8 | 7 / 9 | 5 / 8 | 5 / 8 |
| Accruals ratio | β | β7.1% | β10.8% | β10.8% | β9.7% | 8.9% |
| Altman Z'' | β | 7.19 | β0.57 | 1.20 | 4.71 | 4.54 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $80.7M | $113M | $228M | $305M | $371M | $489M |
| Net interest income | $0.0M | β$0.2M | β$0.5M | β | β | β |
| Gross profit | $65.3M | $89.9M | $149M | $223M | $279M | $381M |
| Research and development | $39.6M | $51.0M | $102M | $101M | $113M | $128M |
| Operating income | β$16.7M | β$32.3M | β$94.4M | β$30.0M | β$8.0M | $18.8M |
| Pretax income | β$16.3M | β$33.7M | β$91.3M | β$27.6M | β$4.6M | $32.7M |
| Income tax | $0.0M | β$0.1M | $0.3M | $0.6M | β$0.1M | β$118M |
| Net income | β$16.3M | β$33.6M | β$91.6M | β$28.2M | β$4.6M | $151M |
| Net income to common | β$16.3M | β$33.6M | β$91.6M | β$28.2M | β$4.6M | β |
| Diluted EPS | β$0.33 | β$0.65 | β$1.50 | β$0.42 | β$0.06 | $1.77 |
| Diluted shares | 0.05B | 0.05B | 0.06B | 0.07B | 0.07B | 0.09B |
| Cash flow | ||||||
| Cash from operations | β$7.3M | β$12.2M | β$57.1M | $7.5M | $32.6M | $88.6M |
| Capital expenditure | $0.7M | $0.1M | $0.0M | $0.5M | $1.2M | $1.8M |
| Free cash flow | β$7.9M | β$12.2M | β$57.1M | $7.0M | $31.4M | $86.8M |
| Depreciation and amortization | $0.7M | $0.9M | $9.2M | $9.1M | $9.8M | $13.3M |
| Stock-based compensation | $8.1M | $11.8M | $34.7M | $38.5M | $42.3M | $55.5M |
| Acquisitions | $0.0M | $3.0M | $111M | $0.0M | $0.0M | $2.8M |
| Balance sheet | ||||||
| Cash and short-term investments | $56.4M | $231M | $75.4M | $69.0M | $159M | $494M |
| Total debt | β | β | $7.6M | $4.5M | β | β |
| Current assets | β | $257M | $143M | $131M | $241M | $606M |
| Current liabilities | β | $41.4M | $87.6M | $70.8M | $77.3M | $96.8M |
| Inventory | β | $2.0M | $10.8M | $4.1M | $8.1M | $9.9M |
| Property and equipment, net | β | $0.6M | $0.4M | $0.7M | $1.8M | $3.0M |
| Goodwill | β | $31.1M | $134M | $134M | $134M | $135M |
| Intangible assets | β | $8.0M | $52.7M | $45.4M | $40.6M | $38.3M |
| Total assets | β | $302M | $340M | $322M | $442M | $960M |
| Total liabilities | β | $52.3M | $95.1M | $74.7M | $83.0M | $412M |
| Shareholders' equity | $64.2M | $250M | $245M | $247M | $359M | $548M |
| Margins | ||||||
| Gross margin | 80.9% | 79.8% | 65.1% | 73.1% | 75.1% | 77.8% |
| Operating margin | β20.6% | β28.6% | β41.4% | β9.8% | β2.1% | 3.8% |
| EBITDA margin | β19.8% | β27.9% | β37.3% | β6.8% | 0.5% | 6.6% |
| Net margin | β20.3% | β29.8% | β40.1% | β9.3% | β1.2% | 30.8% |
| FCF margin | β9.8% | β10.9% | β25.0% | 2.3% | 8.5% | 17.7% |
| Net interest share of revenue | 0.0% | β0.1% | β0.2% | β | β | β |
| Returns | ||||||
| Return on capital | β | β | β42.2% | β13.0% | β | β |
| Return on capital employed | β | β12.4% | β37.5% | β12.0% | β2.2% | 2.2% |
| Return on equity | β25.4% | β21.4% | β37.1% | β11.5% | β1.5% | 33.3% |
| Return on assets | β | β11.1% | β28.5% | β8.5% | β1.2% | 21.5% |
| Return on tangible equity | β25.4% | β15.9% | β157.5% | β41.5% | β2.5% | 40.2% |
| Growth | ||||||
| Revenue growth | β | 39.7% | 102.7% | 33.4% | 22.0% | 31.8% |
| FCF growth | β | β | β | β | 347.8% | 176.3% |
| Share count change | β | 4.7% | 21.6% | 6.2% | 8.1% | 18.1% |
| Financial health | ||||||
| Debt / equity | β | β | 0.0x | 0.0x | β | β |
| Current ratio | β | 6.2x | 1.6x | 1.9x | 3.1x | 6.3x |
| Quick ratio | β | 6.1x | 1.5x | 1.8x | 3.0x | 6.2x |
| Capital allocation | ||||||
| Capex / revenue | 0.8% | 0.1% | 0.0% | 0.2% | 0.3% | 0.4% |
| Stock comp / revenue | 10.0% | 10.4% | 15.2% | 12.6% | 11.4% | 11.3% |
| Quality scores | ||||||
| Piotroski F-score | β | β | 2.0 | 7.0 | 5.0 | 5.0 |
| Altman Z'' | β | 7.2 | β0.6 | 1.2 | 4.7 | 4.5 |
| Accruals ratio | β | β7.1% | β10.8% | β10.8% | β9.7% | 8.9% |
Source: SEC EDGAR XBRL filings (CIK 0001581760). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.